Even though investigations have found the incidence of occurrence of asbestosis, a lung condition, in the Libby, Montana area to be higher than the U.S. national average for the period from 1979-1998, it has nothing on the Nahariya, Israel or Genoa, Italy. Genoa, is the leader of world lung cancer cases due to Asbestos.

Fluorescence bronchoscopy as a highly sensitive test detects lung cancer at an early stage. The results of the first randomized autofluorescence bronchoscopy study confirmed the superiority of AFB over WLB in detecting premalignant lesions.

Saint Louis University researchers are participating in a clinical trial comparing two standard treatments for early-stage NSCLC (Non-Small Cell Lung Cancer), the most common form of lung cancer.

“Surgery, radiation, or chemotherapy” are the three treatment options a person hears soon after they’re told they have lung cancer. Lung cancer is the third most prevalent cancer in Georgia according to CDC statistics. 

The Environmental Protection Agency declared its first ever public health emergency yesterday in a Montana community where residents were poisoned by asbestos from a nearby mine, the Associated Press reports. At least $125 million over the next five years will go toward cleaning up the town of Libby, where local miners wearing contaminated clothes and shoes unknowingly tracked asbestos from the mine into their homes. Another $6 million of federal grant money will go toward medical care for an estimated 500 people with asbestos-related illnesses. Those include residents of another town, Troy, Mont., who’ve also developed illnesses like lung cancer and asbestosis

According to Dr. David Servan-Schreiber, everyone has cancer cells, but only one out of three develop them. Which means that the other two people have natural defenses. By utilizing the power of a healthy diet, you can prevent, fight, and even treat cancer. Below are the 100 best tips for cooking against cancer.

In a mouse model of advanced non-small cell lung cancer, treatment with the nicotinic acetylcholine receptor antagonist α-cobratoxin (α-CbT) was associated with improved survival, according to research published in the June 15 issue of the American Journal of Respiratory and Critical Care Medicine.

Lung cancer is the leading cause of cancer deaths in the U.S. for both men and women. The rate of lung cancer has been dropping among men, while the rate for women is increasing. According to the National Institutes of Health, tobacco is the key cause of lung cancer. Though not all cases of lung cancer are caused by smoking, many are. In fact, 87 percent of cases can be traced to tobacco use.

The New Mexico Institute of Mining and Technology (NM Tech) will present data from Biomoda, Inc. on its non-invasive, inexpensive and accurate diagnostic test for the early detection of lung cancer at the 13th World Conference on Lung Cancer in San Francisco, CA, July 31 to August 4, 2009.

Clarient, Inc., a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced the launch of a new gene mutation test that can help physicians select the proper therapy for patients with non-small cell lung cancer (NSCLC).